Does antiplatelet therapy increase the risk of hemoptysis during percutaneous transthoracic needle biopsy of a pulmonary lesion?

American Journal of Roentgenology

Volumn 200, Issue 5, 2013, Pages 1014-1019

  Song, Yong Sub ^a   Park, Chang Min ^a   Park, Kyung Woo ^a   Kim, Kwang Gi ^b   Lee, Hyun Ju ^a   Shim, Mi Suk ^a   Goo, Jin Mo ^a  

^a Seoul National University College of Medicine   (South Korea)

^b National Cancer Center   (South Korea)

Author keywords

Antiplatelet; Aspirin; Biopsy; Bleeding; Hemoptysis; PTNB

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; ANTITHROMBOCYTIC AGENT;

ADULT; ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; CUTTING NEEDLE; DISEASE SEVERITY; ECHOGRAPHY; FEMALE; FLUOROSCOPY; HEMOPTYSIS; HUMAN; INFORMED CONSENT; LUNG LESION; MAJOR CLINICAL STUDY; MALE; PARTIAL THROMBOPLASTIN TIME; PERCUTANEOUS TRANSTHORACIC NEEDLE BIOPSY; PRIORITY JOURNAL; PROTHROMBIN TIME; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; TRANSTHORACIC BIOPSY; CLINICAL TRIAL; COMORBIDITY; EPIDEMIOLOGY; INCIDENCE; LIVER TUMOR; MIDDLE AGED; NEEDLE BIOPSY; PATHOLOGY; POSTOPERATIVE COMPLICATION; PREMEDICATION; STATISTICS;

BIOPSY, NEEDLE; CAUSALITY; COMORBIDITY; FEMALE; HEMOPTYSIS; HUMANS; INCIDENCE; LIVER NEOPLASMS; MALE; MIDDLE AGED; PLATELET AGGREGATION INHIBITORS; POSTOPERATIVE COMPLICATIONS; PREMEDICATION; RISK ASSESSMENT;

MLCS; MLOWN;

EID: 84879310060     PISSN: 0361803X     EISSN: 15463141     Source Type: Journal    
DOI: 10.2214/AJR.12.8931     Document Type: Article

References (30)

1. Berquist TH, Bailey PB, Cortese DA, Miller WE. Transthoracic needle biopsy: accuracy and complications in relation to location and type of lesion. Mayo Clin Proc 1980; 55:475-481
2. Cham MD, Lane ME, Henschke CI, Yankelevitz DF. Lung biopsy: special techniques. Semin Respir Crit Care Med 2008; 29:335-349
3. Klein JS, Zarka MA. Transthoracic needle biopsy: an overview. J Thorac Imaging 1997; 12:232-249
4. Manhire A, Charig M, Clelland C, et al. Guidelines for radiologically guided lung biopsy. Thorax 2003; 58:920-936
5. Moore EH. Technical aspects of needle aspiration lung biopsy: a personal perspective. Radiology 1998; 208:303-318
6. Sinner WN. Complications of percutaneous transthoracic needle aspiration biopsy. Acta Radiol Diagn (Stockh) 1976; 17:813-828
7. Tomiyama N, Yasuhara Y, Nakajima Y, et al. CTguided needle biopsy of lung lesions: a survey of severe complication based on 9783 biopsies in Japan. Eur J Radiol 2006; 59:60-64
8. Yankelevitz DF, Davis SD, Chiarella DA, Henschke CI. Pitfalls in CT-guided transthoracic needle biopsy of pulmonary nodules. Radio-Graphics 1996; 16:1073-1084
9. Richardson CM, Pointon KS, Manhire AR, Macfarlane JT. Percutaneous lung biopsies: a survey of UK practice based on 5444 biopsies. Br J Radiol 2002; 75:731-735
10. Yeow KM, Su IH, Pan KT, et al. Risk factors of pneumothorax and bleeding: multivariate analysis of 660 CT-guided coaxial cutting needle lung biopsies. Chest 2004; 126:748-754
11. Yildirim E, Kirbas I, Harman A, et al. CT-guided cutting needle lung biopsy using modified coaxial technique: factors effecting risk of complications. Eur J Radiol 2009; 70:57-60
12. Dominguez MJ, Vacas M, Saez Y, et al. Effects of triflusal in patients with prosthetic heart valves. Clin Ther 1985; 7:357-360
13. Kaushansky K. Thrombopoietin. N Engl J Med 1998; 339:746-754
14. Schafer AI. Effects of nonsteroidal anti-inflammatory therapy on platelets. Am J Med 1999; 106:25S-36S
15. Bertrand ME. When and how to discontinue antiplatelet therapy. Eur Heart J Suppl 2008; 10(suppl A): A35-A41
16. Bell AD, Roussin A, Cartier R, et al. The use of antiplatelet therapy in the outpatient setting: Canadian Cardiovascular Society Guidelines Executive Summary. Can J Cardiol 2011; 27:208-221
17. Collet JP, Himbet F, Steg PG. Myocardial infarction after aspirin cessation in stable coronary artery disease patients. Int J Cardiol 2000; 76:257-258
18. Sibon I, Orgogozo JM. Antiplatelet drug discontinuation is a risk factor for ischemic stroke. Neurology 2004; 62:1187-1189
19. Atwell TD, Smith RL, Hesley GK, et al. Incidence of bleeding after 15,181 percutaneous biopsies and the role of aspirin. AJR 2010; 194:784-789
20. Ibrahim WH. Massive haemoptysis: the definition should be revised. Eur Respir J 2008; 32:1131-1132
21. Heinze G, Schemper M. A solution to the problem of separation in logistic regression. Stat Med 2002; 21:2409-2419
22. Herth FJ, Becker HD, Ernst A. Aspirin does not increase bleeding complications after transbronchial biopsy. Chest 2002; 122:1461-1464
23. Ernst A, Eberhardt R, Wahidi M, Becker HD, Herth FJ. Effect of routine clopidogrel use on bleeding complications after transbronchial biopsy in humans. Chest 2006; 129:734-737
24. Patrono C. Aspirin as an antiplatelet drug. N Engl J Med 1994; 330:1287-1294
25. Jennings LK. Mechanisms of platelet activation: need for new strategies to protect against plateletmediated atherothrombosis. Thromb Haemost 2009; 102:248-257
26. Cattaneo M. P2Y12 receptor antagonists: a rapidly expanding group of antiplatelet agents. Eur Heart J 2006; 27:1010-1012
27. Storey RF. Biology and pharmacology of the platelet P2Y12 receptor. Curr Pharm Des 2006; 12:1255-1259
28. Serebruany VL, Malinin AI, Ferguson JJ, Vahabi J, Atar D, Hennekens CH. Bleeding risks of combination vs. single antiplatelet therapy: a meta-analysis of 18 randomized trials comprising 129,314 patients. Fundam Clin Pharmacol 2008; 22:315-321
29. Hongo RH, Ley J, Dick SE, Yee RR. The effect of clopidogrel in combination with aspirin when given before coronary artery bypass grafting. J Am Coll Cardiol 2002; 40:231-237
30. Yende S, Wunderink RG. Effect of clopidogrel on bleeding after coronary artery bypass surgery. Crit Care Med 2001; 29:2271-2275